Suzanne Elliott joined the Foundation in November 2016 as the Clinical Trial Unit Manager and became Associate Director of Clinical Trials in 2019. Suzanne has been involved in clinical research for over 25 years, with a doctorate in molecular oncology and post-doctorate in infectious/viral/cancer immunology clinical trials. She has a special interest in early phase drug development, Phase I clinical trials, working with a Phase I company for over a decade. She has qualifications in drug development and has extensive experience particularly in ethics and regulatory affairs and Good Clinical Practice. Suzanne’s focus is to provide a professional and supportive role to the Foundation’s clinical team in its aim to pursue clinical research excellence in emerging new therapies that may benefit our patients.